Tonix Pharma (TNXP) Tops Q1 EPS by 16c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of ($0.18), $0.16 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.48 million versus the consensus estimate of $3.87 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold